350 related articles for article (PubMed ID: 18187871)
1. NIS mRNA expression level in resected thyroid tissue as a marker of postoperative hypothyroidism after subtotal thyroidectomy in patients with Graves' disease.
Goto A; Uchino S; Noguchi S; Wakiya S; Watanabe Y; Murakami T; Matsuura B; Onji M
Endocr J; 2008 Mar; 55(1):73-81. PubMed ID: 18187871
[TBL] [Abstract][Full Text] [Related]
2. Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves' disease.
Shimizu K; Kumita S; Kitamura Y; Nagahama M; Kitagawa W; Akasu H; Oshina T; Kumasaki T; Tanaka S
J Am Coll Surg; 2002 Jan; 194(1):14-22. PubMed ID: 11800336
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
Saito T; Endo T; Kawaguchi A; Ikeda M; Nakazato M; Kogai T; Onaya T
J Clin Endocrinol Metab; 1997 Oct; 82(10):3331-6. PubMed ID: 9329364
[TBL] [Abstract][Full Text] [Related]
4. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
5. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
[TBL] [Abstract][Full Text] [Related]
6. The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism.
Lin YS; Lin JD; Hsu CC; Yu MC
J Surg Res; 2017 Dec; 220():112-118. PubMed ID: 29180171
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M
World J Surg; 1992; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
[TBL] [Abstract][Full Text] [Related]
8. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid.
Uyttersprot N; Pelgrims N; Carrasco N; Gervy C; Maenhaut C; Dumont JE; Miot F
Mol Cell Endocrinol; 1997 Aug; 131(2):195-203. PubMed ID: 9296378
[TBL] [Abstract][Full Text] [Related]
9. Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction.
Kuma K; Matsuzuka F; Kobayashi A; Hirai K; Fukata S; Tamai H; Miyauci A; Sugawara M
Am J Med Sci; 1991 Jul; 302(1):8-12. PubMed ID: 1676563
[TBL] [Abstract][Full Text] [Related]
10. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
Cochrane Database Syst Rev; 2015 Nov; (11):CD010576. PubMed ID: 26606533
[TBL] [Abstract][Full Text] [Related]
11. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
Mori Y; Matoba N; Miura S; Sakai N; Taira Y
World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
[TBL] [Abstract][Full Text] [Related]
12. Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease.
Wilkin TJ; Gunn A; Isles TE; Crooks J; Beck JS
Lancet; 1979 Jul; 2(8133):63-6. PubMed ID: 87965
[TBL] [Abstract][Full Text] [Related]
13. Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
Nonchev BI; Terzieva DD; Dimov RS; Mateva NG; Tsvetkova TZ; Dimitrakov DY
Folia Med (Plovdiv); 2005; 47(3-4):40-5. PubMed ID: 16761393
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of Graves' disease: subtotal thyroidectomy might still be the preferred option.
Lepner U; Seire I; Palmiste V; Kirsimägi U
Medicina (Kaunas); 2008; 44(1):22-6. PubMed ID: 18277085
[TBL] [Abstract][Full Text] [Related]
16. Changes in the thyroid function of Graves' disease patients treated by subtotal thyroidectomy.
Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
Endocr J; 2012; 59(12):1115-20. PubMed ID: 22971989
[TBL] [Abstract][Full Text] [Related]
17. Regulation and tissue distribution of the human sodium iodide symporter gene.
Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
[TBL] [Abstract][Full Text] [Related]
18. Abnormal TSH Prior to Surgery in Children with Graves' Disease Predicts Abnormal TSH Following Thyroidectomy.
Hazkani I; Stein E; Edwards E; Maddalozzo J; Johnston D; Samis J; Josefson J; Rastatter J
Laryngoscope; 2023 Sep; 133(9):2402-2406. PubMed ID: 36370147
[TBL] [Abstract][Full Text] [Related]
19. Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial.
Witte J; Goretzki PE; Dotzenrath C; Simon D; Felis P; Neubauer M; Röher HD
World J Surg; 2000 Nov; 24(11):1303-11. PubMed ID: 11038198
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
Miccoli P; Vitti P; Rago T; Iacconi P; Bartalena L; Bogazzi F; Fiore E; Valeriano R; Chiovato L; Rocchi R; Pinchera A
Surgery; 1996 Dec; 120(6):1020-4; discussion 1024-5. PubMed ID: 8957489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
